Clozapine Interrupted: APA, Others Seek FDA Forum on REMS

Seven psychiatric groups are calling for the FDA to hold a public advisory committee meeting about its risk evaluation and mitigation strategy (REMS) for the schizophrenia drug clozapine.

Related Keywords

United States ,American , ,American Psychiatric Association ,Institute For Safe Medication Practices ,Drug Administration ,American Association For Community Psychiatry ,National Alliance On Mental Illness ,National Council For Mental ,College Of Psychiatric ,American Psychiatric Nurses Association ,Safe Medication Practices ,American Association ,Community Psychiatry ,Neurologic Pharmacists ,National Alliance ,Mental Illness ,National Association ,State Mental Health Program Directors ,National Council ,Medscape Medical News ,Schizophrenia ,Risk Evaluation And Mitigation Strategies Rems ,Psychosis ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Risk Management ,Cardiac Arrest ,Neutropenia ,